Roche Holding is a pioneer in Healthcare Company with headquarters in Basel, Switzerland. Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology and Respiratory branches Medicines.
Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)
Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)
As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.